Clinical trial
Correlative Biomarker Study for MPD-RC Treatment Studies in the Philadelphia Chromosome Negative MPD
NCT00665067 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Correlative Biomarker Study for MPD-RC Treatment Studies in the Philadelphia Chromosome Negative MPD
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2007
- Completion date
- July 20, 2018
- Enrollment
- 592 (actual)
- Sites
- 22
Conditions
As the registry lists them; a condition with its own page is linked.
essential thrombocythemia, idiopathic myelofibrosis, myelofibrosis, myeloproliferative disease, polycythemia vera